Characterization of serum HER2 ECD level in patients with metastatic colorectal cancer

被引：0
|
作者：
Taniguchi, H. [1 ]
Hasegawa, H. [2 ]
Masuishi, T. [1 ]
Narita, Y. [1 ]
Komori, A. [1 ]
Kadowaki, S. [1 ]
Ura, T. [3 ]
Muro, K. [1 ]
机构：
[1] Aichi Canc Ctr Hosp, Nagoya, Aichi 464, Japan
[2] Osaka Natl Hosp, Dept Gastroenterol & Hepatol, Osaka, Japan
[3] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
10.1093/annonc/mdv233.229
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-232
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Serum HER2 in the context of circulating tumor cells in patients with metastatic breast cancer.
    Mueller, Volkmar
    Riethdorf, Sabine
    Rack, Brigitte Kathrin
    Janni, Wolfgang
    Fasching, Peter A.
    Solomayer, Erich
    Aktas, Bahriye
    Kasimir-Bauer, Sabine
    Pantel, Klaus
    Fehm, Tanja N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Pretreatment serum level of HER2/nue as a prognostic factor in metastatic prostate cancer patients about to undergo endocrine therapy
    Okegawa, Takatsugu
    Kinjo, Manami
    Nutahara, Kikuo
    Higashihara, Eiji
    INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (09) : 1197 - 1201
  • [43] Prospective Evaluation of Serum HER2 and HER2 Expression on Circulating Tumor Cells in Patients with Metastatic Breast Cancer within the DETECT Study
    Mueller, V
    Riethdorf, S.
    Rack, B.
    Janni, W.
    Fasching, P.
    Pantel, K.
    Gebauser, G.
    Solomayer, E.
    Aktas, B.
    Kasemier-Bauer, S.
    Fehm, T.
    CANCER RESEARCH, 2009, 69 (24) : 662S - 662S
  • [44] Targeting HER2 in colorectal cancer
    Spitzer, Eleonore
    Cervera, Pascale
    Andre, Thierry
    Cohen, Romain
    BULLETIN DU CANCER, 2023, 110 (04) : 402 - 411
  • [45] Predictive value of serum HER2/neu ECD during trastuzumab-based therapy in patients with breast cancer
    Köstler, WJ
    Schwab, B
    Singer, CF
    Neumann, R
    Marton, E
    Brodowicz, T
    Steger, G
    Wiltschke, C
    Krainer, M
    Zielinski, CC
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S109 - S109
  • [46] Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy
    Jun Zhou
    Zhi Peng
    Yi Liu
    Jifang Gong
    Xiaotian Zhang
    Ming Lu
    Jing Gao
    Yili Li
    Yanyan Li
    Lin Shen
    Journal of Gastroenterology, 2016, 51 : 509 - 510
  • [47] Prognostic impact of circulating HER2 extracellular domain (ECD) in women with metastatic breast cancer.
    Zheng, Yabing
    Shao, Xiying
    Wang, Xiaojia
    Shi, Lei
    Huang, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Clinical utility of SERUM extracelullar domain of HER2 receptor (ECD) in HER2-positive breast cancer.
    Gasol Cudos, Ariadna
    Morales Murillo, Serafin
    Veas Rodriguez, Joel
    Canosa Morales, Caries
    Mele Olive, Jordi
    Salud, Antonia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [49] Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab
    R. Liu
    X. Zhao
    W. Guo
    M. Huang
    L. Qiu
    W. Zhang
    Z. Zhang
    W. Li
    X. Zhu
    Z. Chen
    Clinical and Translational Oncology, 2020, 22 : 928 - 934
  • [50] Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab
    Liu, R.
    Zhao, X.
    Guo, W.
    Huang, M.
    Qiu, L.
    Zhang, W.
    Zhang, Z.
    Li, W.
    Zhu, X.
    Chen, Z.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (06): : 928 - 934
12345